DURAPHAT

Brand name authorized in: Finland France Ireland Netherlands New Zealand Poland Singapore

Active ingredients

The drug DURAPHAT contains one active pharmaceutical ingredient (API):

1 Sodium fluoride
UNII 8ZYQ1474W7 - SODIUM FLUORIDE

Sodium fluoride is indicated for the prevention of dental caries in adolescents and adults, particularly amongst patients at risk from multiple caries (coronal and/or root caries). The primary mode of the caries preventative action of fluoride is post-eruptive, i.e topical action. Systemic fluoride supplements are believed also to act mainly topically (i.e during ingestion, via saliva).

Read about Sodium fluoride

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Sodium fluoride
A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AA Caries prophylactic agents
Discover more medicines within A01AA01

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 018759, 071589, 416859, 425288, 428133
FR
Base de données publique des médicaments
Identifier(s): 60681425, 64351019
NL
Z-Index G-Standaard, PRK
Identifier(s): 131733, 131741, 150266
NZ
Medicines and Medical Devices Safety Authority
Identifier(s): 2607
PL
Rejestru Produktów Leczniczych
Identifier(s): 100076483, 100227203
SG
Health Sciences Authority
Identifier(s): 07802P